Effects of Dimethylbenzanthracene on Mouse Ovaries and Tumor Development
Author Information
Author(s): June Marchant
Primary Institution: Cancer Research Laboratories, Medical School, Birmingham
Hypothesis
Does treatment with dimethylbenzanthracene (DMB) induce ovarian and breast tumors in mice?
Conclusion
The study found that DMB treatment led to a high incidence of granulosa-celled tumors in the ovaries and breast tumors in mice.
Supporting Evidence
- The first changes in ovaries were a decrease in follicle numbers, disappearing by the 4th month.
- Granulosa-celled tumors were found from the 3rd month onwards, with about three-quarters secreting estrogen.
- Breast tumors appeared in the majority of mice after the 4th month of treatment.
Takeaway
Researchers painted a chemical on mice to see if it would make them sick, and it did, causing tumors in their ovaries and breasts.
Methodology
Eighty-five virgin female F1 hybrid mice were treated with DMB through skin paintings and examined histologically at monthly intervals.
Limitations
The study was limited by the time frame of observation, as many mice had to be killed due to rapid tumor growth.
Participant Demographics
Female F1 hybrid mice derived from C57 B1 mothers and IF fathers.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website